Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体 (PE)
Our Local Distributor
北京 101111
Quick Overview for Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体 (PE) (ABIN7867345)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
原理
- PE-conjugated Anti-KIR2DL2(lirilumab biosimilar) mAb
-
亚型
- IgG4
-
-
-
-
应用备注
- Flow Cyt 1:100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- Store at 2°C-8°C for 6 months
-
有效期
- 6 months
-
-
- KIR2DL2 (Lirilumab Biosimilar)
-
别名
- lirilumab biosimilar
-
物质类
- Biosimilar
-
背景
-
Synonyms: CD158b,CD158B1,NKAT-6,NKAT6,p58.2,BMS-986015, IPH2102
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P43627
抗原
-